2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2002
November 04, 2002
OLSC Names Aegera As One Of Canada’s Top Ten Biotechnology Investment And/Or Partnering Prospects For A Second Year
October 02, 2002
Aegera Therapeutics announces the completion of its second non exclusive adenovirus technology license
September 25, 2002
Aegera Therapeutics appoints Donald Olds as Chief Financial Officer
September 17, 2002
Hybridon and Aegera announce research and development collaboration to develop antisense drug for XIAP gene
March 04, 2002
Aegera Therapeutics announces completion of $17 million private placement
About Aegera
|
Pipeline
|
Clinical Trials
|
Partnerships
|
Media
|
Careers
|
Contact Us
|
Français
© 2010 Aegera Therapeutics Inc. All rights reserved. Developed by
Grafika Designs
.
